Home » Ligand Earns $2 Million Milestone
Ligand Earns $2 Million Milestone
Ligand Pharmaceuticals has announced that the company has earned a $2 million milestone payment from GlaxoSmithKline with that company's filing of an IND for SB-559448, a small-molecule drug that mimics the activity of thrombopoietin, a protein factor that promotes growth and production of blood platelets.
()a href="http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050606005479&newsLang=en" target="_blank">Business Wire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May